NEW YORK, Aug. 21, 2019 /PRNewswire/ -- The GO2 Foundation for Lung Cancer, the United States' leading lun

HONG KONG, Aug. 21, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the first quarter fiscal 2020 on Tuesday, August 27, 2019, after the market close.  The Company will host a conference call at 8:00 a.m. ET on

PHILADELPHIA, Aug. 21, 2019 /PRNewswire/ -- As PREIT (NYSE: PEI) furthers its strategic approach in bolstering health and wellness segments at its properties, the company today announced the addition of P

STAINES-UPON-THAMES, United Kingdom, Aug. 21, 2019 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a global biopharmaceutical company, will present on

DENVER, Aug. 21, 2019 /PRNewswire/ -- DaVita Kidney Care, celebrated its 2019 sustainability milestones, including: Earning Leadership

BURBANK, Calif., Aug. 21, 2019 /PRNewswire/ -- State leaders, health plans, and provider organizations met today for the California Transformation Summit to announce major results of the largest collaborative initiative in history to improve health care quality, and discuss next steps.With more than $52 million in grants from the Cent

NORTH CHICAGO, Ill., Aug. 21, 2019 /PRNewswire/ -- In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, AbbVie Inc. confirms that as of August 19, 2019 its issued share capital, excluding treasury shares, is comprised of 1,478,768,075 shares of common stock with a par value of $

LUND, Sweden, Aug. 21, 2019 /PRNewswire/ -- BioInvent International AB (publ) (OMXS: BINV), a company focused on the discovery and development of novel and first-in-class immuno-modulatory antibodies to treat cancer, today announced that the earlier communicated phase l/lla clinical trial in solid cancer will be conducted with BI-1206, one of BioInvent's proprietary anti

LUND, Sweden, Aug. 21, 2019 /PRNewswire/ -- Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced today that the Company's management team will participate in the following upcoming investor conferences:The Goldman Sachs Ninth Annual Biotech Symposium in London

STOCKHOLM, Aug. 21, 2019 /PRNewswire/ --Important events April – JuneThe US Food and Drug Administration, FDA, approves NeuroVive's IND (Investigational New Drug) application, enabling clinical studies in the US with the company's drug candidate NeuroSTAT. The Supreme Court delivers its ruling concerning arbitrati